Navigation Links
Pre-Marital HIV Testing To Be Made Compulsory In AP, India

Andhra Pradesh, one of the large states of India accounts for 1.5 million of India's 5.7 million HIV/AIDS affected people.//

The government of Andhra Pradesh is set to make it compulsory for couples to take a HIV test before marrying. This is done with a motive of putting an end to the birth of HIV positive babies from 2007.

"Since condom use is not very popular, we are considering tough measures like HIV testing before registration of weddings," Health Minister K. Rosaiah told reporters.

The minister plans to ask legislators to sign a bill in the next session of the state assembly, which is expected to start in March.

But UNAIDS, the United Nations agency fighting HIV/AIDS, does not approve of this move. "Compulsory testing will not work," said UNAIDS India chief Denis Broun.

“This would only result in the boom of fake HIV-negative certificates which could result in serious social and health consequences for couples and their families,” he said.

“The government should focus instead on providing free pre-marriage counseling on a range of issues, including health,” he added.

Majority of the state officials welcome the Health Minister’s suggestion.

“It will be morally good if both the men and women undergo a HIV test before getting into wedlock," Chief Minister Y.S. Rajasekhara Reddy said at the inauguration of a HIV testing camp for MLAs (elected representatives in the state assembly).



'"/>




Page: 1

Related medicine news :

1. Pre-Marital Sex Is Normal Behavior In Americans
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Laboratory Testing Can Identify Risk of Pre-Term Labor and Delivery
4. Testing for blood sugar levels made easier
5. DNA Testing For More Accurate Results
6. SARS vaccine shows promise in Animal Testing
7. Testing Of Saliva May Predict Dental Caries
8. Diagnosing Sleep Apnea By Overnight Sleep Testing Method
9. Testing genes for disease does not cause harm to children of people with Alzheimers
10. Testing Your Health & Charging Your Mobile At One Go - Check Out The Urine Powered Batteries
11. Testing For HIV/AIDS Compulsory For New Military Recruits
Post Your Comments:
(Date:12/2/2008)...oday, advocates for teen,dating violence educatio...iz,Claiborne Inc. to launch ,MADE, -- Moms and Da...nd Chris Burke, educators and parents of Lindsay A...iend, are joining efforts with Liz,Claiborne Inc....hat will,consist of parents, teachers and concern...
(Date:12/2/2008)...erts say , , TUESDAY, Dec. 2 (HealthDay ... prevent cardiac arrest and deaths in critically i...s. , "Many hospitals have implemented these tea... Paul S. Chan, a cardiologist at the Mid America H...s had shown that rapid response teams may decrease...
(Date:12/2/2008)...l about 13 years younger than their chronological ...rthcoming in the Journals of Gerontology: Psychol...onses of 516 men and women age 70 and older who pa... their perceptions about age and their satisfactio...People generally felt quite a bit younger than the...
(Date:12/2/2008)...ire-USNewswire/ -- Students interested in nursing ...he N.C. Nurse Scholars Program (NSP) for the 2009-...CFNC.org. Approximately 400 new awards are availa...rolina State Education Assistance Authority (NCSEA... 1989 to address the dwindling supply of qualified...
Breaking Medicine News(10 mins):Health News:Parents of Murdered Dating Violence Victim, Legislators, and Teachers Unite to Launch 'MADE' - Moms and Dads for Education to Stop Teen Dating Abuse 2Health News:Parents of Murdered Dating Violence Victim, Legislators, and Teachers Unite to Launch 'MADE' - Moms and Dads for Education to Stop Teen Dating Abuse 3Health News:Rapid Response Teams Don't Cut Hospital Heart Attacks, Death Rates 2Health News:Rapid Response Teams Don't Cut Hospital Heart Attacks, Death Rates 3Health News:Old as you want to be: Study finds most seniors feel younger 2Health News:N.C. Nursing Scholarship Applications Due February 28 for Bachelor's Degrees, May 3 for Associate and Graduate Degrees 2
...fer bouts of nausea and vomiting during their preg...but it but it seems that going through morning sic...s who have conducted a new study and found that wo...s have a 30 percent lower risk of developing breas...
...s smoking rate has shown a decline, thanks to the ... to kick the habit. The statistics in the 2006 re...n comparison to 2002 figures. Over the past year, ...2.5% to 19.9%) and among Hispanics (from 20.2% to ...
...cular on switch triggers gene activity that cause...ties to glucose production in the liver was disco... hospital . The on switch, a protein called CREB...hat binds to a section of DNA near a gene and trig...
...amil Nadu, who allegedly tried to get his 15-year-...erform a caesarean operation , today said the accu... Dr. Murugan rubbished the media reports that he m...leepan Raj, a tenth standard student, operating on...
Other Medicine News:Health News:Morning Sickness may Signify Lower Breast Cancer Risk 2Health News:Morning Sickness may Signify Lower Breast Cancer Risk 3Health News:New York Records Decline in Smoking Rate 2Health News:Research Studies on Molecular Switches of Gene 2
(Date:12/1/2008)...DIEGO, Dec. 1 Vical Inco...eipt of a $1.0 million milestone payment from Merc...ion of a Phase I clinical trial of an investigatio...te vaccine is based on Vical,s DNA gene delivery t...nscriptase (hTERT). hTERT is the subject of separa...
(Date:11/27/2008)...study finds the majority of acute lymphoblastic le...sent at the time of diagnosis , , MEMPHIS, ...ts at St. Jude Children,s Research Hospital have i...r cells of children with acute lymphoblastic leuke... pathway to designing treatments for ALL relapse i...
(Date:11/25/2008)...SVILLE, Ky., Nov. 25 Kl...rgeons performed the fifth U.S. hand transplant on...at Louisville,s Jewish Hospital Hand Care Center o...egan around noon and was completed shortly after 9... http://www.newscom.com/cgi-bin/prnh/20081125/DC48...
(Date:11/25/2008)...Patients Enrolled in Clinical Trial to Assess Surv... Care Therapies for Unresectable Hepatocellular Ca...swire/ -- Light Sciences Oncology, Inc. (LSO) toda...al Phase 3 clinical trial of Light Infusion Therap...epatocellular carcinoma (HCC), also known as hepat...
Breaking Medicine Technology:Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4Pipeline for New Obesity Therapies is Focus of New Report 9146 1Pipeline for New Obesity Therapies is Focus of New Report 9146 2Kiwa Fertilizers Pass Independent Tests 2483 1Kiwa Fertilizers Pass Independent Tests 2483 2Kiwa Fertilizers Pass Independent Tests 2483 3DRI Capital Launches Structured Finance Fund 2479 1DRI Capital Launches Structured Finance Fund 2479 2Jazz Pharmaceuticals Inc Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate 1150 1Jazz Pharmaceuticals Inc Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate 1150 2Jazz Pharmaceuticals Inc Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate 1150 3
... 21, 2007 - Medical,professionals seeking to treat...red gram-negative pneumonia may have a new weapon:...andidate being,developed by Nektar Therapeutics (N... evaluating the use of,NKTR-061 (Inhaled Amikacin)...spital-acquired gram-negative pneumonia were,prese...
...RK, Calif.--(BUSINESS WIRE)--May,21, 2007 - ChemGe...,the publication of new clinical data relevant to ...rringtonine). The paper "Targeted,therapy and the ...,by researchers Simona Soverini and colleagues at ...lume 92, pages 401-404) offers,insight into the gr...
Other Medicine Technology:Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 2Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 3Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 4Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 5Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 6Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 7Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 8Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 9Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 10Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 11Independent Publication Confirms Growing Therapeutic Challenge of,T315I Mutation in Patients with CML, Notes ChemGenex 2Independent Publication Confirms Growing Therapeutic Challenge of,T315I Mutation in Patients with CML, Notes ChemGenex 3
GE Healthcare is known as an innovator in best-in-class analysis programs for every major care area monitoring device. With advanced programs such as 12SL, Gender-Specific, and ACI-TIPI, GE can help
For use in vitreo-retinal procedures with a non contact system, and compatible with the Oculus BIOM system, this lens delivers the highest image clarity available in a non contact surgical lens.
The Affinity pacemaker family offers some of today's smallest, truly automatic devices. Featuring the most effective combination of advanced technologies ever seen, the Affinity DR pacemaker incorpor
The IsoFlex lead family features St. Jude Medical's premier passive-fixation pacing leads. The lead is available in both polyurethane (IsoFlex P lead) and silicone (IsoFlex S lead) models, atrial J a
Medicine Products: